ArticleJournal of translational medicine2025

CX26 promotes pancreatic cancer progression by competitively inhibiting interaction of c-Myc with PSMD2 and enhancing c-Myc stability.

Cheng He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.